This is a randomized study of ASSIP as a treatment for patients who have recently made a suicide attempt. Six psychiatric clinics from four regions in Sweden are included. Together 460 patients will be recruited. Patients will be randomized to ASSIP as a supplement to treatment as usual or to treatment as usual only.
The overall aim of the study is to evaluate whether ASSIP, a short-term clinical intervention, can prevent future suicidal behavior in people who have attempted suicide better than just conventional treatment. The project also investigates whether there are any specific factors that may be related to ASSIP's potential effectiveness and whether ASSIP has health economic benefits.
Only patients who give their written consent will be included in the study. Those who meet the inclusion and no exclusion criteria at screening / visit 1 undergo an assessment according to an interview protocol, self-assessment form, and self-assessment scales. Thereafter, the patient is randomized via an electronic system to either ASSIP plus standard treatment or only standard treatment. All patients, regardless of which treatment they are randomized to, will be followed up for two years with a telephone interview and self-assessment scales month 3, 12 and 24. Data from medical records and registers will also be collected.
Age ≥18 years.
Signed informed consent to participate in the study.
Contact with psychiatric health care after a suicide attempt within 3 months before the baseline visit
Booked meeting or visit in psychiatry or primary care after visit 1
Psychotic illness with current delusions, hallucinations or other negative symptoms that may affect the therapy.
Known emotionally unstable personality disorder (ICD 10) noted in the medical record
Inability to undergo therapy without an interpreter
Mental retardation, dementia, or other circumstances that make it difficult to understand the meaning of participating in the study and giving informed consent.